Brainsway Ltd (BWAY) - Total Liabilities

Latest as of March 2026: $41.20 Million USD

Based on the latest financial reports, Brainsway Ltd (BWAY) has total liabilities worth $41.20 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Brainsway Ltd to track the company's year-over-year net asset growth rate.

Brainsway Ltd - Total Liabilities Trend (2000–2025)

This chart illustrates how Brainsway Ltd's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Brainsway Ltd to measure how efficiently the company converts operating cash flow to free cash.

Brainsway Ltd Competitors by Total Liabilities

The table below lists competitors of Brainsway Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Gladstone Commercial Corporation NASDAQ:GOOD	USA	$1.07 Billion
CSB Bank Limited NSE:CSBBANK	India	Rs528.32 Billion
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. SHE:301096	China	CN¥1.30 Billion
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	China	CN¥88.79 Million
SZZT Electronics Co Ltd SHE:002197	China	CN¥4.21 Billion
Bright Minds Biosciences Inc NASDAQ:DRUG	USA	$3.83 Million
Selamat Sempurna Tbk JK:SMSM	Indonesia	Rp897.15 Billion
China Fortune Land Development Co Ltd SHG:600340	China	CN¥259.93 Billion

Liability Composition Analysis (2000–2025)

This chart breaks down Brainsway Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BWAY stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.54	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.35	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Brainsway Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Brainsway Ltd (2000–2025)

The table below shows the annual total liabilities of Brainsway Ltd from 2000 to 2025.

Year	Total Liabilities	Change
2025-12-31	$39.70 Million	+24.04%
2024-12-31	$32.00 Million	+49.61%
2023-12-31	$21.39 Million	+12.11%
2022-12-31	$19.08 Million	+3.66%
2021-12-31	$18.41 Million	+28.03%
2020-12-31	$14.38 Million	-0.96%
2019-12-31	$14.52 Million	-12.82%
2018-12-31	$16.65 Million	+16.36%
2017-12-31	$14.31 Million	+47.87%
2016-12-31	$9.68 Million	+3.52%
2015-12-31	$9.35 Million	-8.30%
2014-12-31	$10.19 Million	+219.03%
2013-12-31	$3.20 Million	+14.95%
2012-12-31	$2.78 Million	-92.03%
2000-12-31	$34.88 Million	--

About Brainsway Ltd

NASDAQ:BWAY USA Medical Devices

Market Cap

$611.17 Million

Market Cap Rank

#11092 Global

#2886 in USA

Share Price

$15.23

Change (1 day)

-0.13%

52-Week Range

$11.59 - $26.04

All Time High

$26.04